@article{Löfvendahl_Norlin_Schmitt-Egenolf_2023, title={Economic Burden of Palmoplantar Pustulosis in Sweden: A Population-based Register Study}, volume={103}, url={https://medicaljournalssweden.se/actadv/article/view/4501}, DOI={10.2340/actadv.v103.4501}, abstractNote={<p class="p1">The aim of this study was to estimate the economic burden of palmoplantar pustulosis, a chronic relapsing skin condition commonly occurring in combination with psoriasis vulgaris. Using data from the Swedish National Patient Register and Swedish Prescribed Drug Register for 2015, the study estimated all-cause and palmoplantar pustulosis-specific healthcare resource use (inpatient stays, physician visits and drug use) for 14,715 patients with palmoplantar pustulosis, and compared these both with matched controls from the general population and with patients with psoriasis vulgaris (without palmoplantar pustulosis). Mean annual direct costs for a patient with palmoplantar pustulosis was higher compared with costs for the general population (3,000 vs 1,700 Euro, <em>p </em>< 0.001). Compared with psoriasis vulgaris, more patients with palmoplantar pustulosis had inpatient stays, but fewer had physician visits and psoriasis-related drugs; the overall costs were similar. Only a small fraction of the costs of physician visits and inpatient stays for patients with palmoplantar pustulosis were attributable to specific palmoplantar pustulosis problems, indicating a clear comorbidity burden in palmoplantar pustulosis.</p>}, journal={Acta Dermato-Venereologica}, author={Löfvendahl, Sofia and Norlin, Jenny M. and Schmitt-Egenolf, Marcus}, year={2023}, month={Jan.}, pages={adv00843} }